Drawing for Serial No. 79445951

USPTO serial 79445951

Serial No. 79445951

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
OSGOOD, KRYSTINA E
Law office
TMO LAW OFFICE 121

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with Serial No. 79445951?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medical preparations and substances; preparations for use in targeted and personalized pharmaceutical therapies; pharmaceutical preparations and substances for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; biopharmaceuticals for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; drugs for medical purposes; oral drugs for medical purposes; drugs for medical use for the degradation of toxins; pharmaceutical preparations in the fields of medicine, health, neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; biological preparations for medical purposes; biological compounds for use in targeted and personalized pharmaceutical therapies; proteins, reagents and cultures, all for medical purposes; proteins with diagnostic and therapeutic uses; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic test kits for medical purposes.ACTIVE—
042Drug development services; scientific consultancy; laboratory services; provision of information and data relating to medical research and development; medical and pharmacological research and development services; scientific research; biochemical and biological research; clinical research; laboratory research; research and development services in the field of medical therapeutics, including in the fields of neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; research and development services in the field of drug development, protein testing, and degradation of aggregated proteins; research, development and design of scientific and medical testing and screening products; scientific testing services; biological testing; information, consultancy and advisory services relating to the aforesaid.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026RFNTREFUSAL PROCESSED BY IB—
Jul 18, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 18, 2026RFRRREFUSAL PROCESSED BY MPU—
May 30, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 29, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2026DOCKASSIGNED TO EXAMINER—
May 14, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 19, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance